Niki BioSolutions, Inc. NIKI

Healthcare — Biotechnology

4.76 (0.21) (4.23%) as of 25 Sep

Market cap: $6.2M
P/E: 0.0×

Follow NIKI

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Sep '25	Dec '25
ROE Full definition →	+8 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(16.25)	(11.01)	(3.77)	(2.90)
Capital Expenditures Full definition →		0.14	—	—	0.13
Other line items
Cash ROIC Full definition →		(103.13%)	(55.46%)	(20.05%)	(14.68%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.48	—	—	0.00
Capex/Depreciation Full definition →		0.06	—	—	0.08
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	—	—	0.00
Capex to Sales Full definition →		0.00	—	—	0.00

Fold the line items

Columns are period end dates